<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33533830</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2317-1782</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>CoDAS</Title><ISOAbbreviation>Codas</ISOAbbreviation></Journal><ArticleTitle>Speech intelligibility in people with Amyotrophic Lateral Sclerosis (ALS).</ArticleTitle><Pagination><StartPage>e20190214</StartPage><MedlinePgn>e20190214</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1590/2317-1782/20202019214</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2317-17822021000100301</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate speech intelligibility and dysarthria, correlated to the functional assessment of Amyotrophic Lateral Sclerosis (ALS).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Quantitative-descriptive study approved by REC under No. CAAE 62912416.4.0000.5404, comprised of 19 individuals with sporadic or familiar ALS. Data were collected using the Dysarthria Protocol and the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-Re). We used visual analogue scale (VAS) to assess speech intelligibility and summary measures; and Spearman's coefficients of correlation for the instruments with significance level of 5%.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Speech intelligibility is compromised (41.37&#xb1;39.73) in varied degrees with positive correlation with the general degree of dysarthria (p=&lt;.0001), and with all the analyzed speech parameters, indicating impact on the speech deterioration of the studied group. There is negative correlation between speech intelligibility and the results of the bulbar sections - speech and deglutition (p=0.0166), arm - activities with the upper limb (p=0.0064) and leg - activities with the lower limb (p=0.0391). Breathing (p=0.0178), phonation (p=0.0334) and resonance (p=0.0053) parameters showed a negative correlation with the item "speech" of the ALSFRS-Re.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Results show impaired speech intelligibility and dysarthria, and evidence breathing, phonation and resonance as important markers of the disease progression. A thorough and early evaluation of the oral motor production allows for a better management of alterations in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leite Neto</LastName><ForeName>Lavoisier</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7796-5973</Identifier><AffiliationInfo><Affiliation>Programa de P&#xf3;s-gradua&#xe7;&#xe3;o Sa&#xfa;de, Interdisciplinaridade e Reabilita&#xe7;&#xe3;o, Faculdade de Ci&#xea;ncias M&#xe9;dicas, Universidade Estadual de Campinas - UNICAMP - Campinas (SP), Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fran&#xe7;a J&#xfa;nior</LastName><ForeName>Marcondes Cavalcante</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0003-0898-2419</Identifier><AffiliationInfo><Affiliation>Departamento de Neurologia, Faculdade de Ci&#xea;ncias M&#xe9;dicas, Universidade Estadual de Campinas - UNICAMP - Campinas (SP), Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chun</LastName><ForeName>Regina Yu Shon</ForeName><Initials>RYS</Initials><Identifier Source="ORCID">0000-0002-5305-7081</Identifier><AffiliationInfo><Affiliation>Programa de P&#xf3;s-gradua&#xe7;&#xe3;o Sa&#xfa;de, Interdisciplinaridade e Reabilita&#xe7;&#xe3;o, Faculdade de Ci&#xea;ncias M&#xe9;dicas, Universidade Estadual de Campinas - UNICAMP - Campinas (SP), Brasil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>por</Language><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Inteligibilidade de fala em pessoas com Esclerose Lateral Amiotr&#xf3;fica (ELA).</VernacularTitle><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Codas</MedlineTA><NlmUniqueID>101623246</NlmUniqueID><ISSNLinking>2317-1782</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004401" MajorTopicYN="N">Dysarthria</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013060" MajorTopicYN="N">Speech</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013064" MajorTopicYN="N">Speech Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013065" MajorTopicYN="Y">Speech Intelligibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013068" MajorTopicYN="N">Speech Production Measurement</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">Avaliar a inteligibilidade de fala e disartria, correlacionando com a avalia&#xe7;&#xe3;o funcional da ELA.</AbstractText><AbstractText Label="M&#xc9;TODO" NlmCategory="UNASSIGNED">Estudo quantitativo-descritivo aprovado pelo CEP, sob n&#xba; CAAE 62912416.4.0000.5404, constitu&#xed;do por 19 pessoas com ELA, espor&#xe1;dica ou familiar. Para coleta, aplicou-se o Protocolo de Disartria e Escala de Avalia&#xe7;&#xe3;o Funcional da Esclerose Lateral Amiotr&#xf3;fica (ALSFRS-Re). Para an&#xe1;lise, foi utilizada escala visual anal&#xf3;gica para inteligibilidade de fala e medidas de resumo e correla&#xe7;&#xe3;o dos instrumentos pelo Coeficiente de Spearman com n&#xed;vel de signific&#xe2;ncia de 5%.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">A inteligibilidade de fala est&#xe1; comprometida (41,37&#xb1;39,73) em graus variados com correla&#xe7;&#xe3;o positiva com o grau geral de disartria (p=&lt;,0001) e com todos os par&#xe2;metros de fala analisados, indicando impacto na deteriora&#xe7;&#xe3;o da fala do grupo estudado. H&#xe1; correla&#xe7;&#xe3;o negativa entre inteligibilidade de fala e resultados das se&#xe7;&#xf5;es bulbar &#x2013; fala e degluti&#xe7;&#xe3;o (p=0,0166), bra&#xe7;o &#x2013; atividades com membro superior (p=0,0064) e perna &#x2013; atividades com membro inferior (p=0,0391). Os par&#xe2;metros de respira&#xe7;&#xe3;o (p=0,0178), fona&#xe7;&#xe3;o (p=0,0334) e resson&#xe2;ncia (p=0,0053) apresentaram correla&#xe7;&#xe3;o negativa com o item &#x201c;fala&#x201d; do ALSFRS-Re.</AbstractText><AbstractText Label="CONCLUS&#xc3;O" NlmCategory="UNASSIGNED">Os achados mostram preju&#xed;zo da inteligibilidade de fala e disartria e evidenciam respira&#xe7;&#xe3;o, fona&#xe7;&#xe3;o e resson&#xe2;ncia como importantes marcadores da progress&#xe3;o da doen&#xe7;a. Uma avalia&#xe7;&#xe3;o criteriosa e precoce da produ&#xe7;&#xe3;o motora oral permite melhor gerenciamento das altera&#xe7;&#xf5;es na ELA.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>3</Day><Hour>12</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33533830</ArticleId><ArticleId IdType="doi">10.1590/2317-1782/20202019214</ArticleId><ArticleId IdType="pii">S2317-17822021000100301</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>